24
Participants
Start Date
October 23, 2012
Primary Completion Date
November 2, 2012
Study Completion Date
December 25, 2012
Klaribact 500 mg Clarithromycin Tablet
A single dose consisting of one Tablet of either test drug (Klaribact 500 mg) or reference drug (Klaricid 500mg) administered to each of the subjects in fasting condition with 240 mL water in both Periods alternatively.
Klaricid 500 mg Clarithromycin Tablet
A single dose consisting of one Tablet of either test drug (Klaribact 500 mg) or reference drug (Klaricid 500mg) administered to each of the subjects in fasting condition with 240 mL water in both Periods alternatively.
Center for Bioequivalence Studies and clinical research (CBSCR), ICCBS, Karachi
Merck Pvt. Ltd, Pakistan
UNKNOWN
Center for Bioequivalence Studies and Clinical Research
OTHER
University of Karachi
OTHER